Perspective of patients with autoimmune diseases on COVID-19 vaccination

Lancet Rheumatol. 2021 Apr;3(4):e241-e243. doi: 10.1016/S2665-9913(21)00037-0. Epub 2021 Feb 22.

Laura Boekel¹, Femke Hooijberg¹, Zoé L E van Kempen², Erik H Vogelzang³, Sander W Tas⁴, Joep Killestein², Michael T Nurmohamed^{1

4}, Maarten Boers^{1

3}, Taco W Kuijpers⁵, S Marieke van Ham^{6

7}, Filip Eftimov⁸, Luuk Wieske⁸, Theo Rispens⁷, Gertjan J Wolbink^{1

7}

¹ Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam 1056 AB, Netherlands.
² Department of Neurology, Vrije Universiteit, Amsterdam UMC, Amsterdam, Netherlands.
³ Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, Amsterdam, Netherlands.
⁴ Amsterdam Rheumatology and Immunology Center, Department of Rheumatology and Clinical Immunology, University of Amsterdam, Amsterdam, Netherlands.
⁵ Department of Pediatric Immunology, Vrije Universiteit, Amsterdam UMC, Amsterdam, Netherlands.
⁶ Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, Netherlands.
⁷ Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, Amsterdam, Netherlands.
⁸ Department of Neurology and Neurophysiology, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, Netherlands.

No abstract available